Non Small Cell Lung Cancer Treatment Algorithm

Radiotherapy should be considered for high risk patients with stage ii disease positive or close margins lymph node involvement in the mediastinum and or extracapsular extension.

Non small cell lung cancer treatment algorithm.

Small cell lung cancer sclc is an aggressive malignancy. The treatment options for non small cell lung cancer nsclc are based largely on the stage extent of the cancer. The previous standard of care in metastatic non small cell lung cancer nsclc was to treat patients with a platinum doublet for four to six cycles and to offer second line therapy upon progression the emergence of molecular testing specifically for the epidermal growth factor receptor egfr and for anaplastic lymphoma kinase alk enables us to better tailor. Postoperative radiotherapy in non small cell lung cancer.

The treatment options for non small cell lung cancer nsclc are based mainly on the stage extent of the cancer but other factors such as a person s overall health and lung function as well as certain traits of the cancer itself are also important. It primarily develops in older adult smokers. Non small cell lung cancer t3 n0 stage iib bronchoscopy mediastinoscopy or endobronchial ultrasound fine needle aspiration ebus fna brain mri for symptomatic patients t1 2 n0 pulmonary function tests pathology 1 consistent with non small cell lung cancer history and physical chest x ray laboratory studies to. Approximately two thirds of patients have evidence of distant metastasis at presentation.

Treatment recommended for some patients in selected patient group. Systematic review and meta analysis of individual patient data from nine randomised.